Puma Biotechnology (PBYI) Depreciation and Depletion (2011 - 2026)
Puma Biotechnology (PBYI) reported Depreciation and Depletion of $100000.0 for Q1 2026, little changed on a YoY basis from $100000.0 in Q1 2025, and little changed quarter-over-quarter from $100000.0 in Q4 2025.
Puma Biotechnology (PBYI) Depreciation and Depletion (2011 - 2026) Analysis & Trends
Puma Biotechnology has reported Depreciation and Depletion for 9 years, with the latest figure at $100000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation and Depletion changed 0.0% year-over-year to $100000.0; the trailing twelve-month figure through Mar 2026 stood at $400000.0 (changed 0.0% YoY), and the FY2025 full-year result was $400000.0, changed 0.0% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $100000.0, roughly flat from $100000.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $200000.0 in Q1 2022, with the low at $100000.0 in Q2 2022.
- Historically, Depreciation and Depletion has averaged $111764.7 across 5 years, with a median of $100000.0 in 2022.
- The largest YoY upside for Depreciation and Depletion was 0.0% in 2022 against a maximum downside of 50.0% in 2022.
- Puma Biotechnology's Depreciation and Depletion stood at $100000.0 in 2022, then changed by 0.0% to $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025, then changed by 0.0% to $100000.0 in 2026.
- The last three Depreciation and Depletion figures came in at $100000.0 (Q1 2026), $100000.0 (Q4 2025), and $100000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Puma Biotechnology | 384.39 Mn | 282.84 Mn | 34.39 Mn | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 100,000.00 |
| Dec 31, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |